Analysis of superoxide dismutase 1, dual-specificity phosphatase 1, and transforming growth factor, beta 1 genes expression in keratoconic and non-keratoconic corneas

Samira Saee-Rad, Reza Raoofian, Mirgholamreza Mahbod, Mohammad Miraftab, Majid Mojarrad, Soheila Asgari, Farhad Rezvan, Hassan Hashemi, Samira Saee-Rad, Reza Raoofian, Mirgholamreza Mahbod, Mohammad Miraftab, Majid Mojarrad, Soheila Asgari, Farhad Rezvan, Hassan Hashemi

Abstract

Purpose: To quantitatively assess the superoxide dismutase 1 (SOD1), transforming growth factor, beta 1 (TGF-β1), and dual-specificity phosphatase 1 (DUSP1) messenger ribonucleic acid (mRNA) expression levels as the main intracellular reactive oxygen species neutralizers, wound healing mediators, and immunomodulators (respectively) in keratoconic (KCN) and non-KCN corneas.

Methods: Total RNA was extracted from normal and keratoconic cultured corneal stromal fibroblasts. Semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) was used to measure the relative expression levels of mRNAs of the SOD1, TGF-β1, and DUSP1 genes.

Results: The mRNA expression of TGF-β1 and DUSP1 was augmented in the KCN corneas (three- and fivefold, respectively; both p<0.05). The KCN and non-KCN samples showed no difference in comparative SOD1 mRNA levels.

Conclusions: This study demonstrated a higher level of DUSP1 and TGF-β1 expression as known molecules in the inflammatory process. These results may provide new insight into the complex molecular pathways underlying KCN for investigating other inflammatory molecules.

Figures

Figure 1
Figure 1
Primary corneal tissue culture. This figure represents primary tissue culture from sample no. 4 under light microscopy. A: The migration of cells out of the tissue started on day 7 after seeding (white arrow shows margin of tissue, 10X magnification). B: One of the cell colonies was performed after 15 days post-seeding (20X magnification). C, D: After cell culture expansion, the cultivated cells were starved for 24 h to compare the morphological difference between fibroblasts and keratocytes (C, D, respectively).
Figure 2
Figure 2
Determination of the exponential cycle of amplification. Semiquantitative reverse transcription–polymerase chain reaction (RT–PCR) mixtures were taken for five alternating cycles starting at cycles 18, 21, 24, 27, and 30 for A: beta 2 microglobulin (B2M), B: superoxide dismutase 1 (SOD1), C: dual-specificity phosphatase 1 (DUSP1), and D: transforming growth factor, beta 1 (TGF-B1). Cycle 24 was selected as an exponential cycle.
Figure 3
Figure 3
Differential messenger ribonucleic acid expression of the target genes via semiquantitative reverse transcription–polymerase chain reaction (RT-PCR; 24th cycle). This figure shows the results of the RT–PCR products in 2% agarose gel electrophoresis, stained with ethidium bromide. Lanes 1 to 10: Keratoconus (KCN) corneas; lane 11: pooled normal corneas and lane 12: negative control without RT. The fluorescent intensity of the bands was quantified with a GS-800 densitometer. The signal intensities were normalized to values obtained for beta 2 microglobulin (B2M). The messenger ribonucleic acid (mRNA) expression of transforming growth factor, beta 1 (TGF-β1), and dual-specificity phosphatase 1 (DUSP1) was increased in the KCN corneas (three- and fivefold, respectively; both p<0.05). The comparative superoxide dismutase 1 (SOD1) mRNA level showed no difference between the KCN and non-KCN samples.
Figure 4
Figure 4
The comparative mRNA expression of target genes in ten keratoconus (KCN) and pooled normal corneal tissues. This graph indicates the comparison of transcript band intensities for genes encoding superoxide dismutase 1 (SOD1), transforming growth factor, beta 1 (TGF-β1), and dual-specificity phosphatase 1 (DUSP1) between the KCN and non-KCN samples. The values were calculated relative to the beta 2 microglobulin (B2M) levels (as normalizer) and reported as mean percentages. Note that the KCN corneas showed a three- and fivefold increase in TGF-B1 and DUSP1 when compared to the pooled normal corneas. The RNA levels for SOD1 were similar for the KCN and normal corneas (p<0.05). Normal corneal samples were pooled to reduce tissue preparation errors. The error bars represent the standard deviation.

References

    1. Gillan W. The stroma and keratoconus: a review. S Afr Optom. 2007;66:87–93.
    1. Abu-Amero KK, Kalantan H, Al-Muammar AM. Analysis of the VSX1 gene in keratoconus patients from Saudi Arabia. Mol Vis. 2011;17:667–72.
    1. Sharma R, Titiyal JS, Prakash G, Sharma N, Tandon R, Vajpayee RB. Clinical profile and risk factors for keratoplasty and development of hydrops in north Indian patients with keratoconus. Cornea. 2009;28:367–70.
    1. Kennedy RHBW, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986;101:267–73.
    1. Balasubramanian SA, Pye DC, Willcox MDP. Are proteinases the reason for keratoconus? Curr Eye Res. 2010;35:185–91.
    1. Saee-Rad S, Hashemi H, Miraftab M, Noori-Daloii MR, Chaleshtori MH, Raoofian R, Jafari F, Greene W, Fakhraie G, Rezvan F, Heidari M. Mutation analysis of VSX1 and SOD1 in Iranian patients with keratoconus. Mol Vis. 2011;17:3128–36.
    1. Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003;26:139–46.
    1. Kenney MC, Nesburn AB, Burgeson RE, Butkowski RJ, Ljubimov AV. Abnormalities of the extracellular matrix in keratoconus corneas. 1997. p. 345.
    1. Tuori A, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Springer; 1997. p. 222–9.
    1. Kao WWY, Vergnes JP, Ebert J, Sundar-Raj CV, Brown SI. Increased collagenase and gelatinase activities in keratoconus. Elsevier; 1982. p. 929–36.
    1. Wilson SEKW. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220–6.
    1. SE W. Stimulus-specific and cell type-specific cascades:emerging principles relating to control of apoptosis in the eye. Exp Eye Res. 1999;69:255–66.
    1. SE W. Role of apoptosis in wound healing in the cornea. Cornea. 2000;19(Suppl 3):S7–12.
    1. Li Y, Twining SS, Sugar J, Yue BY. Involvement of Sp1elements in the promoter activity of the alpha1-proteinase inhibitor gene. J Biol Chem. 1998;273:9959–65.
    1. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.
    1. Arnal E, Peris-Martínez C, Menezo JL, Johnsen-Soriano S, Romero FJ. Oxidative stress in Keratoconus? Invest Ophthalmol Vis Sci. 2011;52:8592–7.
    1. Udar N, Atilano SR, Brown DJ, Holguin B, Small K, Nesburn AB, Kenney MC. SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci. 2006;47:3345–51.
    1. Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13:679–92.
    1. Hammer M, Echtenachter B, Weighardt H, Jozefowski K, Rose‐John S, Männel DN, Holzmann B, Lang R. Increased inflammation and lethality of Dusp1−/− mice in polymicrobial peritonitis models. Immunology. 2010;131:395–404.
    1. Schweikl H, Hiller K-A, Eckhardt A, Bolay C, Spagnuolo G, Stempfl T, Schmalz G. Differential gene expression involved in oxidative stress response caused by triethylene glycol dimethacrylate. Biomaterials. 2008;29:1377–87.
    1. Chen J, Chen Y, Han SN. Comparison of TGF-β1 in tears and corneal haze following Epi-LASIK with and without mitomycin C. Int J Ophthalmol. 2013;6:312–5.
    1. Romero-Jiménez M, Santodomingo-Rubido J, Wolffsohn JS. Keratoconus: a review. Cont Lens Anterior Eye. 2010;33:157–66.
    1. Atilano SR, Coskun P, Chwa M, Jordan N, Reddy V, Le K, Wallace DC, Kenney MC. Accumulation of mitochondrial DNA damage in keratoconus corneas. Invest Ophthalmol Vis Sci. 2005;46:1256–63.
    1. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94:514–9.
    1. Chwa M, Atilano SR, Reddy V, Jordan N, Kim DW, Kenney MC. Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest Ophthalmol Vis Sci. 2006;47:1902–10.
    1. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. SAGE Publications; 2002. p. 341.
    1. McMonnies CW. Abnormal rubbing and keratectasia. Eye Contact Lens. 2007;33:265–71.
    1. Kallinikos P, Efron N. On the etiology of keratocyte loss during contact lens wear. Invest Ophthalmol Vis Sci. 2004;45:3011–20.
    1. McMonnies CW. Mechanisms of rubbing-related corneal trauma in keratoconus. Cornea. 2009;28:607–15.
    1. Israeli O, Goldring-Aviram A, Rienstein S, Ben-Baruch G, Korach J, Goldman B, Friedman E. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet. 2005;160:35–42.
    1. Patterson KI, Brummer T, O'Brien PM, Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J. 2009;418:475–89.
    1. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA. 2006;103:2274–9.
    1. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato ACB, Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med. 2006;203:15–20.
    1. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. ARVO; 1998. p. 471.
    1. Shoham A, Hadziahmetovic M, Dunaief JL, Mydlarski MB, Schipper HM. Oxidative stress in diseases of the human cornea. Elsevier; 2008. p. 1047–55.
    1. Rozalen M, Peris‐Martinez C. Oxidative stress in keratoconus. Acta Ophthalmol (Copenh) 2012;•••:90.
    1. Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, Vasiliou V, Adachi W, Brown DJ. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci. 2005;46:823–32.
    1. Chang WW, Zhang L, Jin Y-l, Yao Y-s. Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer’s disease. J Neural Transm. 2013;120:353–60.
    1. Engler C, Chakravarti S, Doyle J, Eberhart CG, Meng H, Stark WJ, Kelliher C, Jun AS. Transforming Growth Factor-B Signaling Pathway Activation in Keratoconus. Am J Ophthalmol. 2011;151:752–9.
    1. Li DQ, Lee SB, Tseng SCG. Differential expression and regulation of TGF-b1, TGF-b2, TGF-b3, TGF-bRI, TGF-bRII, and TGF-bRIII in cultured human corneal, limbal, and conjunctival fibroblasts. London: IRL Press,[c1981-; 1999. p. 154–61.
    1. Li D-QTS. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61–79.
    1. Massagué J, Wrana JL. The TGF-b family and its composite receptors. Trends Cell Biol. 1994;4:172–8.
    1. Karamichos D, Hutcheon AE. Human corneal fibrosis: an in vitro model. Invest Ophthalmol Vis Sci. 2010;51:1382–8.
    1. Vellucci VF, Reiss M. Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene. Genomics. 1997;46:278–83.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner